drugset

drugset / Trial / NCT00434304

Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)

NCT00434304 ↗

Phase 2 Completed 62 enrolled GlaxoSmithKline

NaSingle-groupOpen-labelTreatment

Summary

This study was designed to evaluate the pharmacokinetic profile, safety and efficacy in Parkinson's Disease patients.

Timeline

Start: 2007-04-09
Primary completion: 2009-03-01
Completion: 2009-03-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ropinirole	Small molecule	—	Oral

Indications